SurvivorNet vs Multiple Myeloma Management使用状況と統計

We believe far too many people still struggle to find information about treatments that can save their lives. SurvivorNet is closing this gap by creating a deep, video-based educational resource for patients featuring top physicians and researchers around the country. To create patient-focused educational content, the company is working with physicians at leading NCCN-designated cancer centers such as The National Cancer Institute, Dana-Farber, Memorial Sloan Kettering, Stanford, NYU, and M.D. Anderson.
  • Apple App ストア
  • 無料
  • ヘルス & フィットネス

ストアランキング

- -

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
  • Apple App ストア
  • 無料
  • 医学

ストアランキング

- -

SurvivorNet対Multiple Myeloma Managementランキング比較

と過去28日間の SurvivorNet ランキング傾向を比較 Multiple Myeloma Management

ランキング

ご利用可能なデータがありません

SurvivorNet 対 Multiple Myeloma Management 国の比較によるランキング

と過去28日間の SurvivorNet ランキング傾向を比較 Multiple Myeloma Management

表示できるデータはありません

無料トライアルで任意のサイトと比較する

始める
SurvivorNet VS.
Multiple Myeloma Management

12月 17, 2024